LCFAOD Symptoms Linked to Alterations in Complex Lipids

LCFAOD Symptoms Linked to Alterations in Complex Lipids. Accumulated altered versions of complex lipids sphingomyelins, ceramides, and cardiolipin are likely responsible for LCFAO symptoms according to a study. A recently published hypothesis article by the International Journal of Molecular Medicine indicates that retinopathy and neurodegenerative symptoms associated with patients that [...]

By |2022-10-24T10:23:53-04:00October 24th, 2022|

Efficacy of a Diet Supplemented With Triheptanoin Proven Greater Than IMB-203 in Treating VLCAD Deficiency

Efficacy of a Diet Supplemented With Triheptanoin Proven Greater Than IMB-203 in Treating VLCAD Deficiency Triheptanoin (C7) has shown effectiveness in treating CoA dehydrogenase VLCAD deficiency, a type of LCFAOD. It has also shown to have greater efficacy than IMB-203. The study found that C7 reduced hepatic steatosis, whereas IMB-203 [...]

By |2022-09-23T11:31:03-04:00September 23rd, 2022|
Go to Top